Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-13,212
Closed -$1.56M – 1168
2026
Q1
$1.56M Buy
13,212
+7,628
+137% +$881K 0.27% 56
2025
Q4
$588K Buy
+5,584
New +$524K 0.09% 422
2025
Q3
– Sell
-16,761
Closed -$1.33M – 1119
2025
Q2
$1.33M Buy
16,761
+8,725
+109% +$694K 0.22% 109
2025
Q1
$721K Buy
+8,036
New +$750K 0.11% 321
2024
Q4
– Sell
-5,894
Closed -$669K – 1062
2024
Q3
$669K Sell
5,894
-10,275
-64% -$1.22M 0.15% 246
2024
Q2
$2M Buy
16,169
+13,164
+438% +$1.7M 0.38% 28
2024
Q1
$397K Sell
3,005
-2,933
-49% -$362K 0.09% 450
2023
Q4
$647K Buy
+5,938
New +$616K 0.17% 209
2022
Q1
– Sell
-4,770
Closed -$366K – 629
2021
Q4
$366K Buy
+4,770
New +$380K 0.22% 163
2019
Q4
– Sell
-2,963
Closed -$238K – 473
2019
Q3
$238K Buy
2,963
+124
+4% +$9.94K 0.22% 239
2019
Q2
$227K Buy
+2,839
New +$217K 0.15% 329
2019
Q1
– Sell
-4,690
Closed -$342K – 613
2018
Q4
$342K Sell
4,690
-3,713
-44% -$262K 0.18% 227
2018
Q3
$569K Buy
8,403
+2,372
+39% +$151K 0.25% 133
2018
Q2
$349K Buy
+6,031
New +$340K 0.11% 376
2017
Q2
– Sell
-17,816
Closed -$1.08M – 749
2017
Q1
$1.08M Buy
17,816
+5,450
+44% +$331K 0.44% 13
2016
Q4
$695K Buy
12,366
+8,174
+195% +$478K 0.37% 40
2016
Q3
$250K Sell
4,192
-943
-18% -$55.1K 0.15% 326
2016
Q2
$282K Buy
+5,135
New +$273K 0.14% 316
2016
Q1
– Sell
-9,327
Closed -$470K – 509
2015
Q4
$470K Buy
+9,327
New +$470K 0.36% 60

Other funds holding MRK

Fox Run Management's MRK Position: Q2 2026 in Review

Fox Run Management sold out of Merck (MRK) in Q2 2026, closing a stake of 13,212 shares — an estimated $1.56M sold.

Fox Run Management first reported a position in MRK in Q4 2015 and held it in 19 quarters. The position peaked at $2M in Q2 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fox Run Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 13,212 Merck shares in Q2 2026, an estimated $1.56M.
  • Fox Run Management first reported a position in Merck in Q4 2015 and held it in 19 quarters.
  • Fox Run Management's Merck position peaked at $2M in Q2 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.